Targeting EGFR resistance networks in head and neck cancer. - Wikidata - wikimedia - TriplyDB

Targeting EGFR resistance networks in head and neck cancer.

Targeting EGFR resistance networks in head and neck cancer.

http://www.wikidata.org/entity/Q37405633

about

Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling.Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.The molecular pathogenesis of head and neck cancer.Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas.EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.Current status of clinical trials in head and neck cancer 2014.Toward Signaling-Driven Biomarkers Immune to Normal Tissue Contamination An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.HIF-1alpha links beta-adrenoceptor agonists and pancreatic cancer cells under normoxic condition.Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma.Nanoparticle encapsulated silver carbene complexes and their antimicrobial and anticancer properties: a perspective.Genomic insights into head and neck cancer.

P2860

Q26852215-BEE46F41-C4AE-4681-912B-D428882FD4D7 Q33466722-059ADC62-0104-4459-9877-088059A04EA3 Q34067863-67456145-44DC-4566-87F1-E9D849FCAE81 Q34436771-D90581F6-641C-4D96-A1C2-12AB5E4DFEE0 Q34452650-C2EFECCC-679A-455F-B742-841ED9F74F2F Q35111736-7D384F4C-EEAB-4D5A-B35A-973E30CDE325 Q35833106-611EA64F-B341-4F38-9A9A-C847D4203179 Q36103054-F5B257EA-BB51-424B-856F-C68C954D7C8E Q36138884-8F81A199-D268-4FB3-8979-167E661A4F56 Q37165861-678D6A44-6175-497F-850F-F950BC4061FF Q37316834-27A2781B-DCAC-4506-8A60-398BC77CAB47 Q37364878-10A7273E-9071-4372-BFDE-C0E3CEEFC1F5 Q37716386-BB488C9F-B604-4094-97E6-740CA4008AC5 Q38326230-522C3679-55DF-4551-8D7F-4FB83DAFA060 Q38369788-8888C6D2-34EA-42B3-8D00-666F4B32DFF3 Q38432573-C6925AAD-D339-4BA7-BE79-8B3C6F266426 Q38768447-097CBAF4-22C6-4385-9AA9-90DE9EC6C997 Q39017499-F61E7A7B-3A25-4FEA-B9F6-A22C9143536C Q39198025-B5605898-965E-402F-ADD5-FCEA52E6BB5C Q39355591-5375EC35-BCFE-44F0-8C18-E7DDDF5D770D Q39462821-BBCB1184-3F95-4A70-AC14-7E8DC7FEA0E8 Q50917827-09D62E34-0EC5-439F-94A2-46904E1BBEFA

P2860

Targeting EGFR resistance networks in head and neck cancer.

http://www.wikidata.org/entity/Q37405633

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting EGFR resistance networks in head and neck cancer.

@en

Targeting EGFR resistance networks in head and neck cancer.

@nl

type

label

Targeting EGFR resistance networks in head and neck cancer.

@en

Targeting EGFR resistance networks in head and neck cancer.

@nl

prefLabel

Targeting EGFR resistance networks in head and neck cancer.

@en

Targeting EGFR resistance networks in head and neck cancer.

@nl

P1433

Q37405633-76032F1B-4B28-495A-87E8-72C99AC41BD7

P1476

Q37405633-94F7FBCE-7A44-4E20-AAC2-9028E5BF1BFF

P2093

Q37405633-10635231-B22E-46D1-8413-1A91EAF4EEE8

Q37405633-9DD4C480-73BC-415E-88D8-35B92164EFB7

Q37405633-CCEF7A4B-1548-4B25-8874-AC21E602E874

Q37405633-E0B82479-A474-41E5-A937-631E732EA245

P2860

Q37405633-0049A7C1-ABA1-4F10-A160-D60B3E70870F

Q37405633-027C0C5E-FA93-4DBF-8053-B3D8C5E65D0E

Q37405633-0582F09F-CB49-4225-AE8E-CACDB2F1E89A

Q37405633-066201AB-E330-4EB6-B83E-D36C3C5BC2C1

Q37405633-089B8D14-EF56-411E-B834-BBD34C21BA0D

Q37405633-09F895A2-5162-45EB-B6C3-449E48B48666

Q37405633-0D7FB9AB-4CAE-4218-922D-D6D650717561

Q37405633-106FEADD-852C-4A80-B50A-C40063A05D21

Q37405633-113CB40C-5421-4AC6-927B-7CF996BEE884

Q37405633-1250D5C3-804D-4897-A4E8-07F87381031F

P304

Q37405633-A21FB143-300C-45AF-B949-F9107DD1BCB4

P31

Q37405633-C080AFA6-BC16-4291-9931-AD5CE0648C08

P356

Q37405633-9B7B9813-922E-49A5-8C2A-871B8DF2BF7B

P433

Q37405633-B63E3375-CA36-424A-8C87-524C2D07AD7D

P478

Q37405633-A7B276C8-66B1-4039-A8DB-2518E4E871CE

P50

Q37405633-6C779BA6-C4B7-4C59-A111-6280C6BA0A68

P577

Q37405633-D50E21CC-2C82-4355-ADE0-3E26868D1507

P5875

Q37405633-DC93CA9C-95FD-497A-BE2F-FAF13CD18E32

P698

Q37405633-F9498FDB-5657-4143-A0F5-12E0D5E8EE8D

P932

Q37405633-CC313DDF-67B1-48CC-AA04-9D98CAD87D43

P356

J.CELLSIG.2009.02.021

P1433

Cellular Signalling

P1476

Targeting EGFR resistance networks in head and neck cancer

@en

P2093

Barbara A Burtness

http://www.w3.org/2001/XMLSchema#string

Erica A Golemis

http://www.w3.org/2001/XMLSchema#string

Igor Astsaturov

http://www.w3.org/2001/XMLSchema#string

Vladimir Ratushny

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

Phosphotyrosine interactome of the ErbB-receptor kinase family

Disruption of epithelial cell-matrix interactions induces apoptosis

ErbB receptors: from oncogenes to targeted cancer therapies

Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

P304

1255-1268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELLSIG.2009.02.021

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Joshua Silverman

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

222309960

http://www.w3.org/2001/XMLSchema#string

P698

19258037

http://www.w3.org/2001/XMLSchema#string

P932

2770888

http://www.w3.org/2001/XMLSchema#string